Pars Darou's CEO Says Monthly Sales Reached 910 Billion Tomans, Lifting the Firm to No. 10 in the Drug Industry

Pars Darou's chief executive (ticker PDRO) said at the company's 66th anniversary ceremony on Wednesday, October 28, 2026 (6 Aban 1405), that monthly sales rose from about 230 billion tomans in Mordad last year to 910 billion tomans in Mordad this year, lifting the company from 24th to 10th place in the drug industry by rial sales. He put production growth at about 400%, beyond the effect of drug price increases.

The CEO said the receivables collection period fell from 359 to 156 days and exports in the first half of this year reached $1.2 million, versus about $1 million for all of last year. These are management statements and have not been checked here against audited financial statements.